entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100289092,ATP2A1-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,2.1115143842701,0.844793683254346,1.50973978230121,0.559562444573513,0.575777927127616,0.961473650102656,NA
100289092,ATP2A1-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,62.0765629615669,-0.477412925816975,0.237006351268761,-2.01434654920111,0.0439731619542828,0.244595730422149,patient-derived GBM cell lines (PDGCLs)
100289092,ATP2A1-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,34.1620468776314,-1.39979061138251,0.395314325603,-3.54095594498709,0.000398680140725729,0.00303842753915001,A549
100289092,ATP2A1-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,23.8062211483541,-0.363590635145041,0.415506092732043,-0.875054882479227,0.381544044316452,0.986418245486816,A549
100289092,ATP2A1-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,46.6302621368257,-1.73952516387317,0.470125793317995,-3.70012704811657,0.000215491557253389,0.000937382572211779,A549
100289092,ATP2A1-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,41.1026446907915,-0.177782143164304,0.360516304524465,-0.493132046826025,0.621919288452115,1,sigmoid colon organoid
100289092,ATP2A1-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,41.1026446907915,-0.670869757451672,0.368689682647126,-1.81960545419917,0.0688191104855474,0.521227837622408,sigmoid colon organoid
